A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer - Concepedia

Concepedia

Publication | Open Access

A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer

DOI Full Paper Access

96

Citations

28

References

2013

Year

Sophie Postel‐Vinay, Ilirjana Bajrami, Luc Friboulet, Richard Elliott, Yari Fontebasso, Nicolas Dorvault, Ken A. Olaussen, Fabrice André, J.C. Soria, Christopher J. Lord,

MedicinePathologyPotential TherapyBronchial NeoplasmCancer GenomicsImmune Checkpoint InhibitorOncologyCell BiologyLung Cancer

References

	Year	Citations

Page 1

Page 1